73 related articles for article (PubMed ID: 25714921)
1. Rituximab increases the cytotoxicities of vincristine and hydroxyurea through caspase-dependent and caspase-independent cell death, respectively.
Tabal S; Elbanani A; Deyab M; Abulayha A
Cancer Biother Radiopharm; 2015 Apr; 30(3):125-31. PubMed ID: 25714921
[TBL] [Abstract][Full Text] [Related]
2. Rituximab synergizes with hydroxyurea or vincristine in the killing of Ramos Burkitt's lymphoma B cell line.
Deyab M; Elbanani A; Tabal S; Geriani H; Lamami Y; Bredan A; Abulayha A
Cancer Biother Radiopharm; 2014 Mar; 29(2):87-90. PubMed ID: 24256491
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea potentiates the caspase-independent killing of B-cell lines by rituximab and GA101.
Daniels I; Abulayha A; Haynes AP
Oncol Res; 2012; 20(12):545-55. PubMed ID: 24139412
[TBL] [Abstract][Full Text] [Related]
4. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
[TBL] [Abstract][Full Text] [Related]
6. CD20-induced B cell death can bypass mitochondria and caspase activation.
van der Kolk LE; Evers LM; Omene C; Lens SM; Lederman S; van Lier RA; van Oers MH; Eldering E
Leukemia; 2002 Sep; 16(9):1735-44. PubMed ID: 12200688
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin enhances (131)I-rituximab induced cell death in Raji cells.
Kumar C; Pandey BN; Samuel G; Venkatesh M
J Cancer Res Ther; 2015; 11(4):823-9. PubMed ID: 26881525
[TBL] [Abstract][Full Text] [Related]
8. Antilymphoma effects of anti-HLA-DR and CD20 monoclonal antibodies (Lym-1 and Rituximab) on human lymphoma cells.
Liu C; DeNardo G; Tobin E; DeNardo S
Cancer Biother Radiopharm; 2004 Oct; 19(5):545-61. PubMed ID: 15650447
[TBL] [Abstract][Full Text] [Related]
9. Bryonia dioica aqueous extract induces apoptosis through mitochondrial intrinsic pathway in BL41 Burkitt's lymphoma cells.
Benarba B; Meddah B; Aoues A
J Ethnopharmacol; 2012 May; 141(1):510-6. PubMed ID: 22465729
[TBL] [Abstract][Full Text] [Related]
10. Caspase-independent killing of Burkitt lymphoma cell lines by rituximab.
Daniels I; Abulayha AM; Thomson BJ; Haynes AP
Apoptosis; 2006 Jun; 11(6):1013-23. PubMed ID: 16544097
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
[TBL] [Abstract][Full Text] [Related]
12. Zinc-mediated regulation of caspases activity: dose-dependent inhibition or activation of caspase-3 in the human Burkitt lymphoma B cells (Ramos).
Schrantz N; Auffredou MT; Bourgeade MF; Besnault L; Leca G; Vazquez A
Cell Death Differ; 2001 Feb; 8(2):152-61. PubMed ID: 11313717
[TBL] [Abstract][Full Text] [Related]
13. Vinorelbine induces apoptosis and caspase-3 (CPP32) expression in leukemia and lymphoma cells: a comparison with vincristine.
Toh HC; Sun L; Koh CH; Aw SE
Leuk Lymphoma; 1998 Sep; 31(1-2):195-208. PubMed ID: 9720729
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop.
von Haefen C; Wieder T; Essmann F; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2003 Apr; 22(15):2236-47. PubMed ID: 12700660
[TBL] [Abstract][Full Text] [Related]
15. Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines.
Sánchez-Hidalgo M; Lee M; de la Lastra CA; Guerrero JM; Packham G
J Pineal Res; 2012 Nov; 53(4):366-73. PubMed ID: 22582944
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM.
Lin CK; Nguyen TT; Morgan TL; Mei RL; Kaptein JS; Kalunta CI; Yen CF; Park E; Zou HY; Lad PM
Exp Cell Res; 1998 Oct; 244(1):1-13. PubMed ID: 9770343
[TBL] [Abstract][Full Text] [Related]
18. The involvement of mitochondria and the caspase-9 activation pathway in rituximab-induced apoptosis in FL cells.
Eeva J; Nuutinen U; Ropponen A; Mättö M; Eray M; Pellinen R; Wahlfors J; Pelkonen J
Apoptosis; 2009 May; 14(5):687-98. PubMed ID: 19308735
[TBL] [Abstract][Full Text] [Related]
19. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B
Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303
[TBL] [Abstract][Full Text] [Related]
20. A requirement for calcium in the caspase-independent killing of Burkitt lymphoma cell lines by Rituximab.
Daniels I; Turzanski J; Haynes AP
Br J Haematol; 2008 Jul; 142(3):394-403. PubMed ID: 18544085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
